Cocaine Metabolite, Screen and Confirmation, Urine (Pain Management)
Use
Detect and confirm the presence of cocaine metabolite
Special Instructions
This assay is specifically not intended for workplace testing and does not comply with state regulatory workplace testing programs. It is crucial for providers to be aware of its intended use for pain management only.
Limitations
This test is not suitable for workplace drug testing and does not comply with associated regulatory requirements. It is designed for pain management settings, potentially limiting its applicability in broader contexts. Sensitivity might vary based on the timing of urine collection post-exposure to cocaine, which can affect metabolite detectability.
Methodology
Immunoassay (CLIA)
Biomarkers
LOINC Codes
- 14314-9
- 14314-9
- 3393-6
- 16226-3
- 77202-0
Result Turnaround Time
3-5 days
Related Documents
For more information, please review the documents below
Specimen
Urine
Volume
20 mL
Minimum Volume
Not provided
Container
Plastic urine container
Storage Instructions
Maintain specimen at room temperature. If arrival at lab will extend beyond seven days, refrigerate.